Across TCGA pan-cancer cohorts, KRTAP3-4P RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated KRTAP3-4P data layer.
The strongest signal is observed in bladder urothelial carcinoma (BLCA), where higher KRTAP3-4P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated KRTAP3-4P expression acts as an unfavorable survival marker.
BLCA, BRCA, and CHOL are the cancer types where KRTAP3-4P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.